Demonstration of the antimyoclonic effect of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) using a new animal model
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 28 (25), 2865-2868
- https://doi.org/10.1016/0024-3205(81)90102-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brainBrain Research, 1979
- STRUCTURE‐ACTIVITY STUDIES ON THE INHIBITION OF GABA BINDING TO RAT BRAIN MEMBRANES BY MUSCIMOL AND RELATED COMPOUNDSJournal of Neurochemistry, 1978
- POST‐MORTEM AND AMINOOXYACETIC ACID‐INDUCED ACCUMULATION OF GABA: EFFECT OF GAMMA‐BUTYROLACTONE AND PICROTOXINJournal of Neurochemistry, 1978
- The action of Baclofen on neurons of the substantia nigra and of the ventral tegmental areaBrain Research, 1977
- Gamma hydroxybutyrateLife Sciences, 1977
- Biochemical Effects of Baclofen (β‐Parachlorophenyl‐GABA) on the Dopamine and the Noradrenaline in the Rat BrainActa Pharmacologica et Toxicologica, 1977
- EEG-synchronizing effect of γ-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain functionNeuropharmacology, 1975
- Central effects of β-(p-chlorophenyl)-γ-aminobutyric acidBrain Research, 1974
- Activities of the National Institute of GeneticsNature, 1972
- 1‐Hydroxy‐3‐amino‐pyrrolidone‐2 (HA‐966): a new GABA‐like compound, with potential use in extrapyramidal diseasesBritish Journal of Pharmacology, 1971